样式: 排序: IF: - GO 导出 标记为已读
-
No test medical abortion - a review of the evidence on selective use of preabortion testing. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-08-12 Amanda Cleeve,Emma Wallengren,Karin Brandell,Sabrina Lee,Margit Endler,John Reynolds-Wright
PURPOSE OF REVIEW The last decade has seen a cascade of different telemedicine models for medical abortion (MA) being tested and implemented. Among these service delivery models is the 'no-test' MA model, in which care is provided remotely and eligibility for the MA is based on history alone. The purpose of this review is to provide an overview of the existing evidence for no-test MA. RECENT FINDINGS
-
New management approaches for female sexual dysfunction. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-07-31 Lori A Brotto,Melanie Altas
PURPOSE OF REVIEW The goal of this paper is to review the most recent studies evaluating treatments for female sexual dysfunction (FSD), including distressing symptoms of desire, arousal, and orgasm disorder. We divide the sections into psychological and pharmacological. RECENT FINDINGS There is excellent evidence in favour of mindfulness, cognitive behavioural therapy, and psychoeducation for improving
-
Adolescent reproductive health in a post-Dobbs landscape: a review. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-07-25 Alexis A Doyle,Serena M Liu,Nichole A Tyson
PURPOSE OF REVIEW To summarize notable recent research in adolescent reproductive health, particularly with respect to a rapidly changing legal landscape surrounding health services that significantly impact adolescent health. RECENT FINDINGS Approval of the first over-the-counter contraceptive pill represented a major advance in adolescent reproductive health, which relied on research regarding its
-
Providing adolescent-friendly sexually transmitted infection screening and treatment services. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-08-14 Julie C Friedman,Bianca Cannon,Nichole Tyson,Melissa Kang
PURPOSE OF REVIEW There are high rates of sexually transmitted infections (STIs) worldwide. Adolescents and young adults (AYA) ages 15-24 years remain one of the populations that is most vulnerable to STIs. The goal of this review is to summarize recent international updates in adolescent STI screening and treatment. RECENT FINDINGS Normalizing sexual history taking and STI testing, and advocating
-
Enhancing equity in cervical screening - initiatives to increase screening participation. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-07-22 Telma Costa,Deborah Bateson,Yin Ling Woo
PURPOSE OF REVIEW Cervical cancer can be eliminated as a public health problem through a three-pillar approach including high coverage of human papillomavirus (HPV) vaccination and HPV-based cervical screening, and treatment of precancers and invasive cancers. However, access inequities prevent many women and people with a cervix benefitting from these life-saving advances. This review focuses on evidence-based
-
Unravelling the vaginal microbiome, impact on health and disease. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-07-15 Erica L Plummer,Lenka A Vodstrcil,Catriona S Bradshaw
PURPOSE OF REVIEW The vaginal microbiome has a fundamental role in supporting optimal vaginal, reproductive, and sexual health. Conversely, dysbiosis of the vaginal microbiome is linked to vaginal symptoms and adverse health outcomes. This review summarizes recent literature concerning the role of the vaginal microbiome in health and disease, with a focus on the most common vaginal dysbiosis, bacterial
-
Two years in a post-Dobbs world: clinical, social and professional consequences. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-07-11 Isabel Beshar,Megan Corn,Paul D Blumenthal
PURPOSE OF REVIEW Dobbs v Jackson Women's Health Organization revoked the decades-old precedent that pregnancy termination is a constitutional right. This review article explores the research landscape describing the consequences of overturning Roe v Wade for patients and providers. RECENT FINDINGS To date, fourteen states have enforced total bans on abortion, with seven more restricting abortion access
-
Reproductive endocrinology and infertility in 2024: promise and turmoil. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-06-27 Ruben Alvero
-
Cutting-edge care: unleashing artificial intelligence's potential in gynecologic surgery. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-06-12 Marie-Claire Leaf,Kelsey Musselman,Karen C Wang
PURPOSE OF REVIEW Artificial intelligence (AI) is now integrated in our daily life. It has also been incorporated in medicine with algorithms to diagnose, recommend treatment options, and estimate prognosis. RECENT FINDINGS AI in surgery differs from virtual AI used for clinical application. Physical AI in the form of computer vision and augmented reality is used to improve surgeon's skills, performance
-
Impact of lifestyle and dietary modifications for endometriosis development and symptom management. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-06-07 Amber Trujillo Lalla,Christina Onyebuchi,Elisa Jorgensen,Nisse Clark
PURPOSE OF REVIEW Management of endometriosis is often complex and poorly studied. Patients with endometriosis have interest in how their lifestyle may affect their diagnosis. Self-management and lifestyle changes are often used as adjunct therapy, but best practices are not concrete in treatment guidelines. RECENT FINDINGS Lifestyle impact on endometriosis and possible self-management treatment therapies
-
Review of sustainable practices for the gynecology operating room. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-28 Elissa Trieu,Laura C Ramirez-Caban,Marie E Shockley
PURPOSE OF REVIEW Climate change has immediate impacts on women's health. Hospitals and operating rooms are large contributors to greenhouse gas (GHG) emissions and waste. This article will review current green initiatives designed to minimize environmental impact in the operating room and highlight areas for future improvement. RECENT FINDINGS From a materials perspective, reusable goods result in
-
Emerging data on diagnosis and management of uterine isthmoceles: a rapid review. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-23 Elizabeth N Cook,Nicholas Jesse,Lara Harvey
PURPOSE OF REVIEW With a rising number of cesarean sections, the prevalence of uterine isthmoceles is increasing. We performed a rapid review to assess the most recent data on the diagnosis and management of uterine isthmoceles over the past 18 months to identify current trends and directions for continued research. RECENT FINDINGS A comprehensive search was conducted in PubMed (NLM), Embase (Ovid)
-
Alternative treatments of adenomyosis - an update in procedural management and clinical outcomes. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-23 Alison M Zeccola,Sarah E Allen
PURPOSE OF REVIEW Adenomyosis is a common cause of abnormal uterine bleeding (AUB), dysmenorrhea, and pelvic pain. Definitive diagnosis and treatment have historically been by uterine histopathology at time of hysterectomy; however, advances in imaging have supported earlier diagnosis and subsequent conservative treatment. This review aims to update the evidence supporting the uterine-sparing, procedural
-
Myofascial pelvic pain: the forgotten player in chronic pelvic pain. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-21 Golnaz Namazi,Navya Chauhan,Stephanie Handler
PURPOSE OF REVIEW In this review article, we discuss myofascial-related chronic pelvic pain, pathophysiology, symptomology, and management options. RECENT FINDINGS Despite high prevalence of myofascial pelvic pain, screening is not routinely performed by providers. Treatment modalities include pelvic floor physical therapy, pelvic floor trigger point injections with anesthetics or botulinum toxin A
-
Ergonomic considerations for unique surgeon populations. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-21 Emily Olig,Gina Ranieri,Michelle Louie
PURPOSE OF REVIEW Surgeons are rapidly diversifying as a population, introducing new ergonomic challenges. This review describes the challenges that are experienced by special populations of surgeons including small-handed surgeons, pregnant surgeons, and trainees, and evidence-based solutions to overcome them. RECENT FINDINGS Small-handed and female surgeons report more musculoskeletal complaints
-
Holistic approach to care for patients with endometriosis. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-21 Andrea Molina,Ashlie Carter,Lacy Alexander,Arpit Davé,Kristin Riley
PURPOSE OF REVIEW Endometriosis is a chronic, often debilitating, disease which is typically managed with surgery and hormonal medications. However, many patients feel they lack agency when managing endometriosis symptoms. The purpose of this review is to discuss the mental and physical management strategies, the long-term health consequences, and the role of a multidisciplinary team in the treatment
-
Advances in gynecologic simulation: implementation, validity, and new resources. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-20 Kathryn Edmonds,Steve Warner,Scott Endicott
PURPOSE OF REVIEW Simulation plays an integral role in gynecological surgical training that will continue and grow in the future. It aims to supplement surgical training as residents are experiencing decreased surgical volumes. It has also been recognized as a means for assessing a trainee's capabilities to the point of being incorporated into the board certification process. This review will highlight
-
Beyond the cuff: a consideration of factors that affect sexual function after benign hysterectomy. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-15 Natalie Cohen,Riley Young,Emily Lin,Lisa Chao
PURPOSE OF REVIEW Hysterectomy is the most common gynecologic surgical procedure performed on women in the United States. While there are data supporting that hysterectomy for benign indication often does not reduce sexual function and may in fact improve sexual function as fibroids and endometriosis are resected, it remains unclear if there are factors within the perioperative period that affect sexual
-
Emerging post-Dobbs liability concerns for providers handling embryos. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-14 Susan L Crockin,Francesca E Nardi
PURPOSE OF REVIEW This review outlines novel, emerging legal risks for in-vitro fertilization (IVF) providers and patients. RECENT FINDINGS This article reviews recent antiabortion legal developments that create novel legal risks to IVF. This article examines new potential liability for the handling or managing of embryos, and threats to safe, efficient, standard-of-care practice of IVF. It reviews
-
Surgical treatment of colorectal endometriosis: an updated review. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-05-13 Rebecca J Schneyer,Kacey M Hamilton,Raanan Meyer,Yosef Y Nasseri,Matthew T Siedhoff
PURPOSE OF REVIEW This review aims to summarize recent literature on the surgical treatment of colorectal endometriosis. RECENT FINDINGS The last decade has seen a surge in the number of studies on bowel endometriosis, with a focus on preoperative evaluation, perioperative management, surgical approach, and surgical outcomes. Many of these studies have originated from large-volume referral centers
-
Recruiting and cultivating future leaders in laboratory science. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-29 Alison Bartolucci,Charlene Alouf,Marlane Angle,Sangita Jindal
PURPOSE OF REVIEW Technological in-vitro fertilization (IVF) advancements originate in the embryology laboratory, and are accompanied by increased regulatory oversight and risk management. Stakes have never been higher or the need greater for the recruitment and cultivation of leaders in laboratory science to navigate the direction of IVF. Current thought leaders in state-of-the-art laboratories must
-
Climate change and human health: a primer on what women's health physicians can do on behalf of their patients and communities. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-25 Ruben Alvero
PURPOSE OF REVIEW To describe the current state of knowledge on the impact on climate change on women's health and to highlight opportunities for healthcare providers to serve as advocates and subject matter experts. RECENT FINDINGS Healthcare providers are a uniquely respected voice in society but have not used this advantage to advocate for their communities and participate in mitigation, adaptation
-
Embryology with precision: effective quality control in the in vitro fertilization laboratory. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-10 Murat Basar,Evrim Unsal,Yagmur Ergun
The purpose of this review is to address the critical need for standardization and clarity in the use of key performance indicators (KPIs) within the realm of in vitro fertilization (IVF), particularly emphasizing the integration of preimplantation genetic testing (PGT) processes. This review is timely and relevant given the persistently modest success rates of IVF treatments, which stand at approximately
-
Beyond the reproductive tract: gut microbiome and its influence on gynecological health Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-09 Inmaculada Pérez-Prieto, Aida Rodríguez-Santisteban, Signe Altmäe
The analysis of microbiome in association with female health is today a "hot topic" with the main focus on microbes in the female reproductive tract. Nevertheless, recent studies are providing novel information of the possible influence of the gut microbiome on gynecological health outcomes, especially as we start to understand that the gut microbiome is an extended endocrine organ influencing female
-
Vaginal dysbiosis - the association with reproductive outcomes in IVF patients: a systematic review and meta-analysis. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-05 Milica Maksimovic Celicanin,Thor Haahr,Peter Humaidan,Axel Skafte-Holm
PURPOSE OF REVIEW To examine impact of vaginal dysbiosis (VD), including bacterial vaginosis (BV) and aerobic vaginitis (AV) on reproductive outcomes of in vitro fertilization (IVF) patients. RECENT FINDINGS BV-bacteria (e.g. Gardnerella ) and AV-bacteria (e.g. Streptococci and Enterococci ) have been identified in the endometrium. However, there is inconclusive evidence whether IVF patients with VD
-
Gender affirming care for the minimally invasive gynecologic surgeon. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-04 Sarah Simko,Otilia Popa,Mallory Stuparich
PURPOSE OF REVIEW Given the current political climate and the release of an updated version of the World Professional Association for Transgender Health's guidelines, this review assesses recent updates in the care of transgender and gender diverse (TGD) patients, specifically related to care provided by gynecologists. RECENT FINDINGS The number of people identifying as TGD and pursuing gender affirming
-
Current applications of artificial intelligence in assisted reproductive technologies through the perspective of a patient's journey. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-04-01 Zoran J Pavlovic,Victoria S Jiang,Eduardo Hariton
PURPOSE OF REVIEW This review highlights the timely relevance of artificial intelligence in enhancing assisted reproductive technologies (ARTs), particularly in-vitro fertilization (IVF). It underscores artificial intelligence's potential in revolutionizing patient outcomes and operational efficiency by addressing challenges in fertility diagnoses and procedures. RECENT FINDINGS Recent advancements
-
Poor ovarian response classification systems in the clinical setting - time for an update? Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-03-27 Andres Reig,Emre Seli
PURPOSE OF REVIEW Poor ovarian response (POR) remains a key challenge to the success of assisted reproductive technology. Here, we offer a comprehensive review of the two main classification systems for POR, discussing their promises and pitfalls, evaluating their performance, and exploring potential avenues for improving upon these definitions of POR. RECENT FINDINGS The Bologna criteria represented
-
Advancements in the application of uterine ultrasound elastography. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-03-26 Francesca Barrett,Stephanie Willson,Marie Werner
PURPOSE OF REVIEW This article reviews recent advances in ultrasound elastography in diagnosing and evaluating the normal nongravid uterus and the infertile uterus in the gynecologic patient. RECENT FINDINGS Focusing on the most recent primary literature, studies have demonstrated new findings among a breadth of gynecologic clinical settings. Studies in the nongravid uterus have found that menopausal
-
Abstinence for sperm sample collection and ART outcome: an unsubstantiated myth. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-03-26 Peter N Schlegel
PURPOSE OF REVIEW Semen analysis is a basic component of male evaluation. Reproductive centers typically instruct men to provide a semen specimen based on recommendations from WHO Standard for semen examination. Evidence that these recommendations optimize sperm reproductive capacity is lacking. Existing data to optimize sperm quality with shorter abstinence were reviewed. RECENT FINDINGS Several recent
-
GnRH agonist trigger in poor prognosis patients undergoing a multicycle approach through DuoStim or consecutive stimulations: a SWOT analysis. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-03-26 Alberto Vaiarelli,Alessandro Ruffa,María Cerrillo,Juan Antonio García-Velasco
PURPOSE OF REVIEW Identify the most recent and significant evidence regarding the ovulation trigger within the framework of a multicycle approach through DuoStim, providing valuable insights for improving treatment strategies in patients with a poor prognosis. RECENT FINDINGS The trigger method plays a pivotal role in optimizing in-vitro fertilization (IVF) stimulation, influencing oocyte retrieval
-
Editorial: Maternal-fetal medicine: old foes and new weapons. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-02-29 Martha Rode,Mark Boddy,Charlotte Conturie
-
Not all platelet-rich plasma are created equal. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-02-05 Manuel Muñoz Cantero
PURPOSE OF REVIEW This review aims to elucidate potential variations in clinical outcomes resulting from the use of different types of platelet-rich plasma (PRPs) in reproductive medicine. It seeks to explore the reasons behind the diverse results reported in various studies and assess the general features distinguishing different PRP formulations. RECENT FINDINGS PRPs have found applications across
-
An update on the current indications for in vitro maturation. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-01-31 Vu N-A Ho,Tuong M Ho,Lan N Vuong,Juan García-Velasco
PURPOSE OF REVIEW In vitro maturation has become a significant component of modern assisted reproductive techniques. Published data have been supported for the safety and effectiveness of in vitro maturation treatment. In recent years, potential indications for in vitro maturation (IVM) have been a topic of interest and investigation. RECENT FINDINGS Significant improvements in technique enhancement
-
Routine screening for gestational diabetes: a review. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-01-15 Minhazur R Sarker,Gladys A Ramos
PURPOSE OF REVIEW Rates of gestational diabetes mellitus (GDM) throughout the world continue to increase associated with the increasing rates of obesity. Given this epidemiologic burden, the importance of proper screening, diagnosis, and management cannot be understated. This review focuses on the current screening guidelines utilized throughout the world and new data recently published regarding the
-
Update on syphilis in pregnancy: marrying basic science advances and clinical perseverance to solve an ancient public health problem. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-01-11 Emily H Adhikari
PURPOSE OF REVIEW While the clinical disease of syphilis, its consequences in pregnancy, and its sensitivity to penicillin treatment have remained relatively unchanged for a century or more, new technologies and basic discoveries in syphilis research have translated into tangible advances in clinical diagnosis, treatment, and prevention. The purpose of this review is to help the reader understand some
-
Pharmacotherapy for opioid use disorder in pregnancy. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-01-05 Cassandra J Trammel,Julia Whitley,Jeannie C Kelly
PURPOSE OF REVIEW Opioid use disorder (OUD) in pregnancy has significantly increased in the last decade, impacting 8.2 per 1000 deliveries. OUD carries significant risk of morbidity and mortality for both the birthing person and neonate, but outcomes for both are improved with opioid agonist treatment (OAT). Here, we describe the recommended forms of OAT in pregnancy, updates to the literature, and
-
Mental health conditions and contraception: current landscape, reproductive health and obstetric outcomes, and clinical guidance. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-01-02 Hayley E Miller,Samantha L Kruger,Danielle M Panelli
PURPOSE OF REVIEW This review presents the epidemiology of mental health conditions among reproductive aged people, common adverse reproductive outcomes, the hormonal profile of contraception and its relationship with psychiatric outcomes, and updated information for clinicians providing contraceptive counselling for this population. RECENT FINDINGS There is variability among contraceptive behaviours
-
The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2024-01-02 David García-Illescas,Roberta Mazzeo,Carmen García-Durán,Ana Oaknin
PURPOSE OF REVIEW This review addresses the emerging role of antibody-drug conjugates (ADCs) in the treatment of ovarian cancer, a field marked by a high need for more effective and targeted therapies. Given the recent advancements in ADC technology and the ongoing challenges in treating ovarian cancer, particularly in late-stage and recurrent cases, this review is both timely and relevant. It synthesizes
-
Evaluating tranexamic acid for the prevention and treatment of obstetric hemorrhage. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-12-26 John J Kowalczyk,Maurizio Cecconi,Alexander J Butwick
PURPOSE OF REVIEW Tranexamic acid (TXA) has emerged as a promising pharmacological adjunct to treat and prevent postpartum hemorrhage (PPH). We provide an overview of TXA, including its pharmacology, key findings of randomized trials and observational studies, and critical patient safety information. RECENT FINDINGS Pharmacokinetic data indicate that TXA infusions result in peak plasma concentration
-
The treatment of endometriosis-associated infertility: Erratum. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-12-20
-
New strategies for the management of triple-negative breast cancer. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-12-08 Fauzia Riaz
PURPOSE OF REVIEW This review highlights important changes in our understanding of triple-negative breast cancer. It highlights important novel approaches in treatment and reviews predicts potential challenges facing the treatment of triple-negative breast cancer. RECENT FINDINGS There is a clear shift away from chemotherapy-centric approaches to the treatment of breast cancer, and instead, a move
-
New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-12-07 Karissa Britten,Nicholas McAndrew
PURPOSE OF REVIEW In recent years, there has been a flurry of activity in the human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer space. New, powerful drugs like trastuzumab deruxtecan have challenged our fundamental definition of what HER2 expression means as a predictive biomarker. RECENT FINDINGS Recent approvals of multiple agents in the second line-metastatic setting
-
Updates in the treatment of HR+HER2- breast cancer. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-12-07 Nikita V Baclig,Kelly E McCann
PURPOSE OF REVIEW Breast cancer (BC) is the most common cancer among women in the United States and the second leading cause of cancer death. BC research, diagnostics, drug development, and expansion of therapies for novel indications advances so rapidly that BC treatment standards change month-by-month. Herein we discuss notable advancements in the past year for hormone receptor positive (HR+) HER2
-
Maintenance therapy for newly and recurrent epithelial ovarian cancer: current therapies and future perspectives. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-12-04 Vanda Salutari,Elena Giudice,Domenica Lorusso
PURPOSE OF REVIEW Epithelial ovarian cancer (EOC) is the fifth cause of cancer death among women, and 70-80% of patients relapse within 2 years from the last cycle of first-line chemotherapy despite a complete response to chemotherapy and optimal debulking surgery. In this context, the goal of the maintenance treatment strategy is to prolong the time to recurrence. The recent development of targeted
-
Editorial: Updates in contraception and abortion care: ghosts of the past, present, and future. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-11-02 Paul D Blumenthal
-
Reducing health disparities in endometrial cancer care in 2024. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-10-25 Chelsea E Stewart,Andrea Nañez,Martins Ayoola-Adeola,Dana Chase
PURPOSE OF REVIEW To summarize the most recent publications explaining disparities among patients diagnosed with endometrial cancer and identify areas of improvement. RECENT FINDINGS Racial disparities in endometrial cancer care have been identified along the cancer continuum including risk, diagnosis, access to treatment, and overall survival. The mortality gap in endometrial cancer is one of the
-
A review of racial disparities in ovarian cancer and clinical trials. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-10-19 Maryam Ali,Krishnansu S Tewari
PURPOSE OF REVIEW Ovarian cancer ranks fifth in mortality among women with cancer and accounts for more death compared to any other gynecological cancers. This review summarizes the most recent literature on disparities in ovarian cancer as well as within recent clinical trials. RECENT FINDINGS Recent studies have identified a notable disparity in genetic testing utilization, disease stage at the time
-
A review of the state of cervical cancer: updates from prevention to recurrent disease. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-10-11 Sarah M Crafton,Puja S Venkat,Ritu Salani
PURPOSE OF REVIEW To summarize the recent updates in cervical cancer from prevention and early detection to the management of early stage and recurrent disease as well as future areas of exploration. RECENT FINDINGS The importance of the human papilloma virus vaccine and screening continue to make an impact in reducing the global burden of cervical cancer. In early-stage, low risk disease, new studies
-
Medical abortion in the second trimester - an update. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-10-09 Helena Kopp Kallner
The safety and efficacy of medical abortion in the second trimester is provider independent and may therefore offer advantages over surgical second trimester abortion in certain settings. Due to bleeding risk, medical abortions in the second trimester are still mostly performed in a clinic or hospital setting. The most effective regimen for abortion includes pretreatment with oral mifepristone and
-
Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimens. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-09-28 Michael Richardson,Dana M Chase
PURPOSE OF REVIEW The scope of immuno-oncology in endometrial cancer has changed rapidly in the last several years, requiring up-to-date knowledge for those who treat these patients. RECENT FINDINGS This article will focus on molecular profiling, recent trials, and FDA approvals of targeted immuno-oncology medications in endometrial cancer. These include immune checkpoint inhibitors alone or with combination
-
Genetic risk assessment in breast and gynecologic malignancies- what's to know in 2024? Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-09-28 Daniella Kamara,Erica Silver,Mariana Niell-Swiller
PURPOSE OF REVIEW Hereditary cancer risk assessment and counseling have become integral in oncology care, especially in breast and gynecologic malignancies where genetic test results impact management. However, a large number of patients who could benefit from genetic testing are not getting tested. As such, genetic risk assessment and counseling methods have had to evolve to meet the needs of this
-
Travel for abortion care: implications for clinical practice. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-09-12 Klaira Lerma,Leah Coplon,Vinita Goyal
PURPOSE OF REVIEW Traveling long distances to obtain abortion care due to restrictions and scarce availability is associated with significant obstacles. We review clinical strategies that can facilitate abortion access and outline considerations to ensure person-centered and equitable care. RECENT FINDINGS Establishing a patient's gestational duration prior to travel may be beneficial to ensure they
-
Controversies in axillary management of patients with breast cancer - updates for 2024. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-09-07 Nikolas Tauber,Vesna Bjelic-Radisic,Marc Thill,Maggie Banys-Paluchowski
PURPOSE OF REVIEW For some time now, the question of de-escalation in axillary staging in breast cancer patients has been raised. The aim is to improve the patients' quality of life and reduce morbidity by optimizing surgical strategies with a high level of oncological safety. This review offers a current overview of published evidence and clinical practice, aiming to guide the surgical community as
-
Cervical preparation for second-trimester procedural abortion. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-08-30 Farsam Fraz,Serena M Liu,Kate A Shaw
PURPOSE OF REVIEW To review the evidence-informed options for cervical preparation prior to second-trimester dilation and evacuation (D&E). RECENT FINDINGS As abortion restrictions increase and the number of abortion clinics and providers decreases, pregnant people are facing more barriers to abortion access. Those in need are now often required to travel for second-trimester abortion care, only to
-
Evaluation and management of urethral and periurethral masses in women. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-08-29 Stephanie W Zuo,Gnankang Sarah Napoe
PURPOSE OF REVIEW Female periurethral masses are an uncommon occurrence. The purpose of this review is to describe etiologies of female urethral and periurethral masses and to provide an update on diagnosis and management. RECENT FINDINGS The most common causes of periurethral and urethral masses in women are urethral caruncles, urethral diverticula, and Skene's gland cysts. Urethral meatal lesions
-
Management of missing intrauterine device strings and migrated intrauterine devices. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-08-21 Stephanie I Amaya,Paul D Blumenthal
PURPOSE OF REVIEW The purpose of this review is to review the recent literature with respect to the management of missing intrauterine device (IUD) strings. As IUD use has increased over time, it is important to review management options for this uncommon but possible complication. RECENT FINDINGS This article will cover stepwise approaches to management of missing IUD strings based on the most recent
-
The evolving role of emergency medicine in family planning services. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-08-17 Carl Preiksaitis,Andrea Henkel
PURPOSE OF REVIEW The emergency department serves as an essential access point for a variety of healthcare services. This review will examine the recent expansion of family planning and reproductive health services in the emergency department. RECENT FINDINGS An increasing number of patients present to emergency departments for early pregnancy loss (EPL), abortion care, and contraceptive management
-
Racial disparities in early pregnancy: a narrative review. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-08-13 Oluremi Mogekwu,Swena Kapoor,Melissa Carmichael,Elizabeth Egbase
PURPOSE OF REVIEW This review introduces the recognized body of evidence on social determinants of health, which continue to show that a person's health is determined by their broader environmental and social context and that societal inequities harm health and healthcare outcomes. An area of inequity is race, which, although a social construct, has a significant impact on a person's morbidity and
-
Update on gestational diabetes and adverse pregnancy outcomes. Curr. Opin. Obstet. Gynecol. (IF 2.2) Pub Date : 2023-08-09 Bryan Ugwudike,ManHo Kwok
PURPOSE OF REVIEW To explore the recent literature concerning the effect of gestational diabetes (GDM) on adverse pregnancy outcomes (APO). RECENT FINDINGS Literature search on PubMed, Medline and British Journal of Obstetrics and Gynaecology was conducted using keywords. Search fields were filtered down to include articles from 2019 onwards. GDM is common during pregnancy and is on the rise because